Clinical Trials

2,000 enrolled

Breast Diseases, Breast Neoplasms

NCT04862429 2026-05-07

BoCCE

184 enrolled

Breast Neoplasms, Calcinosis

NCT05309265 2026-05-07

VocRehab

16 enrolled

Breast Neoplasms

NCT06629896 2026-05-07

CEM

2,200 enrolled

Phase 2 Active not recruiting

Breast Neoplasms, Disease

NCT03756298 2026-04-23

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

284 enrolled

Triple Negative Breast Neoplasms

NCT07540533 2026-04-20

2025-370

92 enrolled

Advanced Breast Cancer

NCT05398861 2026-04-16

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

79 enrolled

HER-2 Negative Breast Cancer

NCT07524829 2026-04-13

Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients

124 enrolled

Treatment Adherence and Compliance, Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT05394285 2026-04-06

A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT05769010 2026-04-01

Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases

150 enrolled

Breast Neoplasms

NCT05318274 2026-03-23

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

72 enrolled

Phase NA Enrolling by invitation

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT07465497 2026-03-12

Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

80 enrolled

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT07467330 2026-03-12

Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

Phase 3 Recruiting

258 enrolled

Breast Neoplasms

NCT07464769 2026-03-11

KompXX

358 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT06704659 2026-03-09

RAY-no-BAN

Breast Neoplasms, Recurrence

NCT07457112 2026-03-09

EHCancer

BreastGastrointestinalLymphoidPlasma cell

212 enrolled

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms

NCT07425379 2026-02-24

Prehabilitation in Breast Cancer Surgery

54 enrolled

Breast Neoplasms

NCT07416253 2026-02-18

Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer

68 enrolled

Breast Neoplasms

NCT07355569 2026-01-23

The Effect on Attendance of an SMS Notification Prior to a Scheduled Screening Appointment in BreastScreen Norway

133,770 enrolled

Phase NA Enrolling by invitation

Attendance

NCT07357207 2026-01-23

VIT-BC

80 enrolled

Female Breast Cancer Patients

NCT06032390 2026-01-14

AIMS Norway

150,000 enrolled

Breast Neoplasms

NCT06967103 2026-01-08

QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer

238 enrolled

Breast Neoplasms

NCT07327021 2026-01-08

NOGA

54 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07301580 2025-12-24

Prehabilitation of Breast Cancer-Related Lymphedema

40 enrolled

Breast Cancer Lymphedema, Fatigue Syndrome, Chronic

NCT02698202 2025-12-19

Screening for Breast Cancer With Digital Breast Tomosynthesis

26,877 enrolled

Breast Neoplasms

NCT07274800 2025-12-10

UHF vs HF-EBC

Breast Neoplasms

NCT06817525 2025-12-05

Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC

64 enrolled

Triple Negative Breast Neoplasms

NCT07256964 2025-12-02

Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer

216 enrolled

Phase 1/2 Active not recruiting

Triple Negative Breast Neoplasms

NCT01992952 2025-11-26

FAKTION

149 enrolled

Estrogen Receptor Positive Breast Cancer

NCT07240584 2025-11-21

Prehab of BC

30 enrolled

Breast Neoplasms, Fatigue, Lymphedema

NCT07243418 2025-11-21

Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study

72 enrolled

Breast Neoplasms

NCT07233863 2025-11-18

Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer

136 enrolled

Breast Neoplasms, Lymphedema

NCT07198672 2025-09-30

Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag

45 enrolled

HER2-positive Breast Cancer

NCT06522971 2025-09-10

CancerBeat

55 enrolled

Breast Neoplasms

NCT07146009 2025-08-28

Targeted Nerve Surgery for the Prevention of Post-Mastectomy Pain Syndrome: A Randomized Trial

Breast Neoplasms

NCT01531036 2025-08-27

3D Breast Ultrasound Elastography in Patients Under Neoadjuvant Chemotherapy

33 enrolled

Malignant Breast Tumours

NCT03232541 2025-08-24

The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting

BreastGastrointestinalGenitourinary

198 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Vomiting, Colorectal Neoplasms

NCT05735795 2025-08-24

Feasibility of Carbon-Dye Marking of Axillary Lymph Nodes Before Neoadjuvant Chemotherapy in Patients With Breast Cancer

50 enrolled

Breast Neoplasms, Lymphatic Metastasis

NCT07136974 2025-08-22

Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.

280 enrolled

Breast Neoplasms

NCT07125950 2025-08-15

SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer

Advanced Breast Cancer

NCT07101159 2025-08-03

Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients

200 enrolled

Breast Neoplasms

NCT03755141 2025-07-22

Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer

Phase 2 Completed

109 enrolled 7 charts

Breast Neoplasms

NCT06243796 2025-07-11

Seroma Formation After Modified Radical Mastectomy With Flap Fixation Technique in Breast Cancer Patients

70 enrolled 8 charts

Breast Neoplasms

NCT04526561 2025-07-09

Reconstructions With Back Donor Site Flaps and Validation of Quality of Life Scales

550 enrolled

Breast Neoplasms

NCT05722795 2025-07-09

I-CONIC

40 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07057427 2025-07-09

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

Phase 3 Recruiting

812 enrolled

Breast Neoplasms

NCT03963427 2025-07-03

GoBreast

220 enrolled

Breast Cancer Female

NCT06195865 2025-07-03

GoBreast II

250 enrolled

Breast Neoplasms

NCT06751407 2025-07-03

Single-level and Two-level Serratus Posterior Superior Intercostal Plan Block (SPSIPB)

50 enrolled